Nordea Investment Management AB Increases Stock Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Nordea Investment Management AB increased its stake in Intuitive Surgical, Inc. by 6.2%, holding a total of 43,921 shares valued at approximately $23.6 million as of the latest SEC filing.
• Multiple institutional investors, including Chilton Capital Management and TD Capital Management, have significantly increased their stakes or initiated new positions in Intuitive Surgical, indicating strong investor interest.
• Analysts have mixed views on the stock, with recent price targets ranging from $525 to $615, reflecting a general consensus rating of "Moderate Buy" with an average target price of $580.29.

Nordea Investment Management AB grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 43,921 shares of the medical equipment provider's stock after buying an additional 2,549 shares during the period. Nordea Investment Management AB's holdings in Intuitive Surgical were worth $23,632,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares during the period. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at $26,000. LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at $30,000. TD Capital Management LLC grew its stake in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after buying an additional 45 shares during the period. Finally, 1248 Management LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research reports. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $600.00 to $536.00 and set an "outperform" rating for the company in a research report on Wednesday. Truist Financial decreased their price target on shares of Intuitive Surgical from $600.00 to $525.00 and set a "buy" rating for the company in a research report on Wednesday. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $615.00 price target on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Finally, Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average target price of $580.29.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $446.13 on Friday. The firm has a 50-day moving average of $454.97 and a two-hundred day moving average of $495.75. The stock has a market cap of $159.93 billion, a P/E ratio of 62.22, a PEG ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm's revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.78 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Amy L. Ladd sold 336 shares of the company's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 in the last ninety days. Insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.